RAB29

Across TCGA pan-cancer cohorts, RAB29 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated RAB29 data layer compared with 24 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher RAB29 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated RAB29 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and LUAD show a favorable association.

CCRCC, LSCC, and HNSC are the cancer types where RAB29 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	II,III,IV	0.964	0.773	.002	45	view →
LSCC	DFS	Quartile	II,III,IV	0.537	0.933	.006	10	view →
HNSC	DFS	Tertile	III,IV	0.739	0.939	.027	5	view →
OV	DFS	Median	All	0.559	0.915	.042	4	view →
LUAD	DFS	Median	All	0.718	0.495	.027	4	view →
PDAC	OS	Median	II,III,IV	0.503	0.303	.044	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RAB29–CCRCC (DFS)

Open the CCRCC breakdown →